June 09, 2026
We are happy to introduce our SOS1 Inhibitor Screening Library, a focused set of 2,600 drug-like compounds designed to identify modulators of the SOS1-KRAS interaction within the RAS-MAPK signaling pathway.
By targeting SOS1, a key activator of RAS, these screening compounds support oncology research programs seeking alternative strategies to inhibit RAS-driven signaling in cancers, particularly pancreatic and lung malignancies.
Developed using structure-based virtual screening and refined with medicinal chemistry filters, the library offers:
- Enriched chemical matter with predicted SOS1 binding
- Reduced assay-interference risk
- Chemically diverse and synthetically accessible compounds
The library is available for prompt delivery.
Contact us at marketing@lifechemicals.com to get the list of compounds or additional details.